Clearbridge Investments, LLC Staar Surgical CO Transaction History

Clearbridge Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$39.39 - $58.12 $58,218 - $85,901	-1,478 Reduced 0.27%	539,905 $21.7 Million
Q2 2023 Aug 11, 2023	BUY	$50.45 - $72.82 $58,774 - $84,835	1,165 Added 0.22%	541,383 $28.5 Million
Q1 2023 May 12, 2023	BUY	$51.25 - $79.34 $765,162 - $1.18 Million	14,930 Added 2.84%	540,218 $34.5 Million
Q4 2022 Feb 10, 2023	BUY	$46.82 - $76.2 $208,395 - $339,166	4,451 Added 0.85%	525,288 $25.5 Million
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $162,265 - $256,634	2,300 Added 0.44%	520,837 $36.7 Million
Q2 2022 Aug 11, 2022	BUY	$50.24 - $80.48 $5.72 Million - $9.16 Million	113,848 Added 28.13%	518,537 $36.8 Million
Q1 2022 May 13, 2022	BUY	$57.98 - $93.5 $23.5 Million - $37.8 Million	404,689 New	404,689 $32.3 Million

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.15B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.